Completed OBSERVATIONAL NCT04329390

MAC Project, Monitoring of AntiCoagulant Therapies (MAC) (MAC)

Sponsor: Quovadis Associazione

Conditions Anticoagulants and Bleeding Disorders

Updated 9 times since 2020 Last updated: May 6, 2025 Started: Mar 1, 2019 Primary completion: Dec 1, 2024 Completion: Dec 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Anticoagulants and Bleeding Disorders and is currently completed. Quovadis Associazione leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Jun 2025 — Sep 2025 [monthly]

Completed

Status: Recruiting → Completed
Sep 2024 — Jun 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2024 — Jul 2024 [monthly]

Recruiting

▶ Show 4 earlier versions

Mar 2023 — Jun 2024 [monthly]

Recruiting
Oct 2021 — Mar 2023 [monthly]

Recruiting
Jan 2021 — Oct 2021 [monthly]

Recruiting
May 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Quovadis Associazione

Data source: Quovadis Associazione

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Padua, Italy